AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 152.6 |
Market Cap | 5.16B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 3.73 |
PE Ratio (ttm) | 42.52 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 158.84 |
Volume | 54,334 |
Avg. Volume (20D) | 130,647 |
Open | 157.57 |
Previous Close | 156.33 |
Day's Range | 156.48 - 158.84 |
52-Week Range | 135.84 - 186.03 |
Beta | undefined |
About BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the...
Analyst Forecast
According to 1 analyst ratings, the average rating for BCPC stock is "Strong Buy." The 12-month stock price forecast is $190, which is an increase of 19.81% from the latest price.
Next Earnings Release
Analysts project revenue of $239.96M, reflecting a 4.92% YoY growth and earnings per share of 1.11, making a 16.84% increase YoY.